Key facts
- This page summarizes Ann K. Donohue's Form 3 filing for SELECTA BIOSCIENCES INC (RNAC).
- 0 reported transactions and 8 derivative rows are listed below.
- Accepted by SEC: 03 Jun 2021, 16:31.
Ann K. Donohue - 27 May 2021 Form 3 Insider Report for SELECTA BIOSCIENCES INC (RNAC)
- Reporting relationship
- VP Finance
- Issuer ticker
- RNAC
- Reported as of
- 27 May 2021
- Net transaction value
- $0
- Reporting owner signature
- Ann K. Donohue
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Ann K. Donohue filed Form 3 for SELECTA BIOSCIENCES INC (RNAC) on 03 Jun 2021.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SELB
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 4,187
- Date
- 27 May 2021
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
SELB
holding
Derivative
Employee Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 27 May 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 5,100
- Exercise price
- $10.89
- Footnotes
- F1
SELB
holding
Derivative
Employee Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 27 May 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,108
- Exercise price
- $17.47
- Footnotes
- F2
SELB
holding
Derivative
Employee Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 27 May 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 10,000
- Exercise price
- $12.46
- Footnotes
- F3
SELB
holding
Derivative
Employee Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 27 May 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 25,000
- Exercise price
- $2.60
- Footnotes
- F4
SELB
holding
Derivative
Employee Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 27 May 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 44,000
- Exercise price
- $1.75
- Footnotes
- F5
SELB
holding
Derivative
Employee Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 27 May 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 15,000
- Exercise price
- $2.30
- Footnotes
- F6
SELB
holding
Derivative
Employee Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 27 May 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 27,000
- Exercise price
- $2.99
- Footnotes
- F7
SELB
holding
Derivative
Restricted Stock Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 27 May 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,250
- Exercise price
- Footnotes
- F8, F9
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 9 footnotes
Footnote F1
This option is fully vested.
Footnote F2
This option is fully vested.
Footnote F3
This option vested as to 25% on June 10, 2019. The remainder of the underlying shares vest in 36 equal monthly installments thereafter.
Footnote F4
This option vested as to 25% on January 7, 2020. The remainder of the underlying shares vest in 36 equal monthly installments thereafter.
Footnote F5
This option vested as to 50% on October 7, 2020, and will be fully vested on October 7, 2021, on which date the other 50% will vest.
Footnote F6
This option vested as to 25% on January 2, 2021. The remainder of the underlying shares vest in 36 equal monthly installments thereafter.
Footnote F7
This option vests as to 25% on January 4, 2022. The remainder of the underlying shares vest in 36 equal monthly installments thereafter.
Footnote F8
This restricted stock unit will vest 25% on January 4, 2022, and will vest in three additional equal annual installments on the anniversary of the grant date, so as to be fully vested on January 4, 2025. The restricted stock units have no expiration date.
Footnote F9
Each restricted stock unit represents a contingent right to receive one share of common stock.